Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02191696 · ClinicalTrials.gov registry record

Observational Study of ICD and Pacemaker Sensing in the Presence of IMED-4 Operation

A clinical trial of Heart Failure, sponsored by Intersection Medical.

Completed
Registry status
24
Enrollment target
2
Study locations

NCT02191696: Completed study of Heart Failure, sponsored by Intersection Medical.

NCT02191696 is a study of Heart Failure that has completed, run by Intersection Medical. The registered enrollment target is 24 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02191696, a study of Heart Failure, has completed, sponsored by Intersection Medical.

COMPLETED
Registry status
24 participants
Enrollment target
2
Study locations

Study Summary

The purpose is to monitor far field sensing artifacts of CRM devices in the presence of the IMED-4

Primary Outcome

The primary endpoint is a collection of CRM device programmer printouts containing real-time lead sensing data from up to 40 unique subjects.

Conditions Studied

Interventions

  • DEVICE IMED-4 recording

Study Locations (2)

California

  • North Coast Cardiology - Encinitas
  • Desert Heart - Palm Springs

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2014-06
Est. Completion 2015-01
Intersection Medical

4 total trials

What the finished NCT02191696 record still lists

NCT02191696 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which IMED-4 recording is the first listed.

NCT02191696 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02191696 about?

NCT02191696 is a clinical study titled "Observational Study of ICD and Pacemaker Sensing in the Presence of IMED-4 Operation". The purpose is to monitor far field sensing artifacts of CRM devices in the presence of the IMED-4

What is the current status of trial NCT02191696?

This trial is currently completed. The enrollment target is 24 participants. The study started on 2014-06. Estimated completion is 2015-01.

What conditions does trial NCT02191696 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT02191696?

The interventions under investigation include: IMED-4 recording (DEVICE).

Who is sponsoring clinical trial NCT02191696?

This trial is sponsored by Intersection Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02191696 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02191696's enrollment target sits among peer trials

24 338th of 397 higher than 58 of 397 other Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02191696, the US trial registry maintained by the National Library of Medicine. NCT02191696 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.